COVID-19 and diabetes mellitus: from pathophysiology to clinical management.

Published on Jan 1, 2021in Nature Reviews Endocrinology28.8
· DOI :10.1038/S41574-020-00435-4
Soo Lim64
Estimated H-index: 64
(Seoul National University Bundang Hospital),
Jae Hyun Bae14
Estimated H-index: 14
(KU: Korea University)
+ 1 AuthorsMichael A. Nauck97
Estimated H-index: 97
(RUB: Ruhr University Bochum)
Initial studies found increased severity of coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients with diabetes mellitus. Furthermore, COVID-19 might also predispose infected individuals to hyperglycaemia. Interacting with other risk factors, hyperglycaemia might modulate immune and inflammatory responses, thus predisposing patients to severe COVID-19 and possible lethal outcomes. Angiotensin-converting enzyme 2 (ACE2), which is part of the renin-angiotensin-aldosterone system (RAAS), is the main entry receptor for SARS-CoV-2; although dipeptidyl peptidase 4 (DPP4) might also act as a binding target. Preliminary data, however, do not suggest a notable effect of glucose-lowering DPP4 inhibitors on SARS-CoV-2 susceptibility. Owing to their pharmacological characteristics, sodium-glucose cotransporter 2 (SGLT2) inhibitors might cause adverse effects in patients with COVID-19 and so cannot be recommended. Currently, insulin should be the main approach to the control of acute glycaemia. Most available evidence does not distinguish between the major types of diabetes mellitus and is related to type 2 diabetes mellitus owing to its high prevalence. However, some limited evidence is now available on type 1 diabetes mellitus and COVID-19. Most of these conclusions are preliminary, and further investigation of the optimal management in patients with diabetes mellitus is warranted.
Figures & Tables
📖 Papers frequently viewed together
11 Citations
10 Citations
14 Citations
#1Javier Perez-Saez (University of Geneva)H-Index: 11
#2Stephen A. Lauer (Johns Hopkins University)H-Index: 16
Last. Alenka Zeballos ValleH-Index: 1
view all 102 authors...
The infection fatality risk (IFR) is the average number of deaths per infection by a pathogen and is key to characterizing the severity of infection across the population and for specific demographic groups. To date, there are few empirical estimates of IFR published due to challenges in measuring infection rates. Outside of closed, closely surveilled populations where infection rates can be monitored through viral surveillance, we must rely on indirect measures of infection, like specific antib...
70 CitationsSource
#1H N Chakravarti (Medical College and Hospital, Kolkata)H-Index: 1
#2A Nag (Medical College and Hospital, Kolkata)H-Index: 1
OBJECTIVE To evaluate the Safety and Efficacy of Hydroxychloroquine as add-on therapy in uncontrolled type 2 diabetes patients who were using two oral antidiabetic drugs. MATERIALS AND METHODS This was a double blind, placebo controlled, parallel group study in 304 inadequately controlled type 2 diabetes (T2DM) subjects with two oral antidiabetic drugs (glimepiride 4 mg and metformin 500 mg) were randomised to hydroxychloroquine (HCQ) 200 mg, 300 mg, 400 mg once daily (OD) or placebo. Dose of hy...
2 CitationsSource
#1Louis Potier (University of Paris)H-Index: 16
#2Jean-Baptiste Julla (University of Paris)H-Index: 3
Last. J.F. Gautier (University of Paris)H-Index: 16
view all 7 authors...
Diabetes & Metabolism - Sous presse. Manuscrit accepte. Disponible en ligne depuis le jeudi 21 mai 2020
9 CitationsSource
#1Anca Pantea Stoian (UMFCD: Carol Davila University of Medicine and Pharmacy)H-Index: 11
#2Doina Catrinoiu (Ovidius University)H-Index: 10
Last. Antonio CerielloH-Index: 108
view all 4 authors...
Hydroxychloroquine has been proposed for the cure of the COVID-19 due to its anti-inflammatory and anti-viral action. People with diabetes are more prone to severe outcome if affected by COVID-19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of Hydroxychloroquine in diabetes deserves particular attention for its documented hypoglycemic action.
5 CitationsSource
#1Anna R. DoverH-Index: 11
#1Anna R DoverH-Index: 1
Last. Fraser W. Gibb (Edin.: University of Edinburgh)H-Index: 13
view all 9 authors...
AIM: To describe the effect of the stringent lockdown measures, introduced in the UK on 23 March 2020 to curtail the transmission of COVID-19, on glycaemic control in people with type 1 diabetes using flash glucose monitoring. METHODS: We undertook an observational study of 572 individuals with type 1 diabetes for whom paired flash glucose monitoring data were available between early March and May 2020. The primary outcome was change in flash glucose monitoring variables. We also assessed clinic...
6 CitationsSource
#1Stephen M. SmithH-Index: 21
#2Avinash BoppanaH-Index: 1
Last. Ruth I Connor (Dartmouth–Hitchcock Medical Center)H-Index: 6
view all 9 authors...
Background Identification of risk factors of severe Covid-19 is critical for improving therapies and understanding SARS-CoV-2 pathogenesis. Methods We analyzed 184 patients hospitalized for Covid-19 in Livingston, New Jersey for clinical characteristics associated with severe disease. Results The majority of Covid-19 patients had diabetes mellitus (DM) (62.0%), Pre-DM (23.9%) with elevated FBG, or a BMI > 30 with normal HbA1C (4.3%). SARS-CoV-2 infection was associated with new and persistent hy...
31 CitationsSource
#1Marco MiraniH-Index: 5
#2Giuseppe FavacchioH-Index: 2
Last. Andrea Lania (Humanitas University)H-Index: 13
view all 8 authors...
OBJECTIVE Diabetes may unfavorably influence the outcome of coronavirus disease 19 (COVID-19), but the determinants of this effect are still poorly understood. In this monocentric study, we aimed at evaluating the impact of type 2 diabetes, comorbidities, plasma glucose levels, and antidiabetes medications on the survival of COVID-19 patients. RESEARCH DESIGN AND METHODS This was a case series involving 387 COVID-19 patients admitted to a single center in the region of Lombardy, the epicenter of...
23 CitationsSource
#1Vincenzo BronteH-Index: 82
#2Stefano UgelH-Index: 26
Last. Oliviero OlivieriH-Index: 65
view all 30 authors...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing pandemic coronavirus disease 2019 (COVID-19). The majority of patients with COVID-19 have a good prognosis, but variable percentages in different countries develop pneumonia associated with lymphocytopenia and severe inflammatory response due to uncontrolled release of cytokines. These immune mediators are transcriptionally regulated by JAK-STAT molecular pathways, which can be disabled by small mo...
43 CitationsSource
#2Simona CostanzoH-Index: 38
Last. Licia Iacoviello (University of Insubria)H-Index: 79
view all 106 authors...
Abstract Background Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19. Objective We set-up a multicenter Italian collaboration to investigate the relationship between HCQ therapy and COVID-19 in-hospital mortality. Methods In a retrospective observational study, 3,451 unselected patients hospitalized in 33 clinical centers in Italy, from February 19, 2020 to May 23, 2020, with laboratory-confirmed SARS-CoV-2 infection, were analyzed. The primary end-point in a time-to eve...
47 CitationsSource
#1Paul Bastard (Rockefeller University)H-Index: 9
#2Lindsey B. Rosen (NIH: National Institutes of Health)H-Index: 17
Last. Jean-Laurent CasanovaH-Index: 162
view all 105 authors...
Interindividual clinical variability in the course of SARS-CoV-2 infection is immense. We report that at least 101 of 987 patients with life-threatening COVID-19 pneumonia had neutralizing IgG auto-Abs against IFN-ω (13 patients), the 13 types of IFN-α (36), or both (52), at the onset of critical disease; a few also had auto-Abs against the other three type I IFNs. The auto-Abs neutralize the ability of the corresponding type I IFNs to block SARS-CoV-2 infection in vitro. These auto-Abs were not...
452 CitationsSource
Cited By56
#1Md. Safaet Hossain Sujan (JU: Jahangirnagar University)H-Index: 2
#2Rafia Tasnim (JU: Jahangirnagar University)H-Index: 4
Last. Shahina Pardhan (ARU: Anglia Ruskin University)H-Index: 25
view all 0 authors...
Abstract null null Background null The COVID-19 pandemic has impacted every individual’s life. It has been shown that mortality in people with underlying diseases including diabetes has been very high. The present study aimed to measure diabetes related worries (outcome) and their associations with social support and lifestyle (exposures) amongst people with diabetes during the COVID-19 pandemic. null null null Methods null An online cross-sectional survey was completed by 928 respondents (>18 y...
#1Nora El-RashidyH-Index: 3
#2Samir Abdelrazik (Mansoura University)
Last. Shaker El-Sappagh (University of Santiago de Compostela)H-Index: 16
view all 0 authors...
Since December 2019, the global health population has faced the rapid spreading of coronavirus disease (COVID-19). With the incremental acceleration of the number of infected cases, the World Health Organization (WHO) has reported COVID-19 as an epidemic that puts a heavy burden on healthcare sectors in almost every country. The potential of artificial intelligence (AI) in this context is difficult to ignore. AI companies have been racing to develop innovative tools that contribute to arm the wo...
#1Egidia Miftode (Grigore T. Popa University of Medicine and Pharmacy)H-Index: 7
#2Larisa Miftode (Grigore T. Popa University of Medicine and Pharmacy)H-Index: 1
Last. Claudia Elena Plesca (Grigore T. Popa University of Medicine and Pharmacy)
view all 0 authors...
Early research into the implications concerning the evolution of the infection caused by the new coronavirus in people with glucose metabolism dysfunction, in this case diabetics, shows that severe forms of the disease predominate in this risk category. Moreover, it seems that even in patients with normal glycaemic status, COVID-19 may predispose to the development of hyperglycaemia which modulates immune mechanisms and inflammatory responses, with direct effects on morbidity and mortality. Thus...
#1Elizabeth Varghese (Qatar Foundation)H-Index: 16
#2Samson Mathews Samuel (Qatar Foundation)H-Index: 24
Last. Dietrich Büsselberg (Qatar Foundation)H-Index: 38
view all 0 authors...
Coronavirus Disease 2019 (COVID-19), caused by a new strain of coronavirus called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), was declared a pandemic by WHO on March 11, 2020. Soon after its emergence in late December 2019, it was noticed that diabetic individuals were at an increased risk of COVID-19-associated complications, ICU admissions, and mortality. Maintaining proper blood glucose levels using insulin and/or other oral antidiabetic drugs (such as Metformin) reduced the...
#1Reda M. Al-Badawy (Banha University)
Last. Mona Ahmed Elawady (Banha University)H-Index: 4
view all 0 authors...
Objectives. This study evaluated the clinical manifestation of COVID-19 and adverse outcomes in patients with comorbidities (outcome: death). Methods. A comparative follow-up investigation involving 148 confirmed cases of COVID-19 was performed for a month (between April and May 2020) at Qaha Hospital to describe the clinical characteristics and outcomes resulting from comorbidities. Participants were divided into two clusters based on the presence of comorbidities. Group I comprised cases with ...
#1Leandro Bueno Bergantin (UNIFESP: Federal University of São Paulo)H-Index: 9
A large amount of evidence has supported a clinical link between diabetes and inflammatory diseases, e g , cancer, dementia, and hypertension null In addition, it is also suggested that dysregulations related to Ca2+signaling could link these diseases, in addition to 3'-5'-cyclic adenosine monophosphate (cAMP) signaling pathways null Thus, revealing this interplay between diabetes and inflammatory diseases may provide novel insights into the pathogenesis of these diseases null Publications invol...
BACKGROUND: Tens of million cases of coronavirus disease-2019 (COVID-19) have occurred globally null The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) attacks the respiratory system, causing pneumonia and lymphopenia in infected individuals null The aim of the present study is to investigate the laboratory characteristics of the viral load, lymphocyte subset and cytokines in asymptomatic individuals with SARS-CoV-2 infection in comparison with those in symptomatic patients with CO...
#1Raymond Pranata (University of Pelita Harapan)H-Index: 19
#2Joshua HenrinaH-Index: 5
Last. Ian Huang (University of Pelita Harapan)H-Index: 14
view all 0 authors...
Diabetes, one of the most prevalent chronic diseases in the world, is strongly associated with a poor prognosis in COVID-19. Scrupulous blood sugar management is crucial, since the worse outcomes are closely associated with higher blood sugar levels in COVID-19 infection. Although recent observational studies showed that insulin was associated with mortality, it should not deter insulin use in hospitalized patients requiring tight glucose control. Back and forth dilemma in the past with regards ...
3 CitationsSource